Related content

Predictive value of ¹⁸F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation

By Qiao Wenli   Zhao Jinhua   Wang Chun   Wang Taisong   Xing Yan  

Hematology, Vol. 15, Iss. 1, 2010-02 ,pp. : 21-27

Maney Publishing

Access to resources Recommend Favorite

Technology: PET/CT and Patient Safety

By  

Joint Commission Perspectives on Patient Safety, Vol. 7, Iss. 10, 2007-10 ,pp. : 5-9

Joint Commission Resources

Access to resources Recommend Favorite

Clinical implication of F-18 FDG PET/CT in patients with secondary hemophagocytic lymphohistiocytosis

By Kim Jahae   Yoo Su   Kang Sae-Ryung   Bom Hee-Seung   Song Ho-Chun   Min Jung-Joon  

Annals of Hematology, Vol. 93, Iss. 4, 2014-04 ,pp. : 661-667

Springer Publishing Company

Access to resources Recommend Favorite

Therapeutic evaluation and prognostic value of interim hybrid PET/CT with ¹⁸F-FDG after three to four cycles of chemotherapy in non-Hodgkin's lymphoma

By Zhao Jinhua   Qiao Wenli   Wang Chun   Wang Taisong   Xing Yan  

Hematology, Vol. 12, Iss. 5, 2007-10 ,pp. : 423-430

Maney Publishing

Access to resources Recommend Favorite

FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin’s lymphoma and Hodgkin’s disease

By Querellou Solène   Valette Frédéric   Bodet-Milin Caroline   Oudoux Aurore   Carlier Thomas   Harousseau Jean-Luc   Chatal Jean-François   Couturier Olivier  

Annals of Hematology, Vol. 85, Iss. 11, 2006-11 ,pp. : 759-767

Springer Publishing Company

Access to resources Recommend Favorite